Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
New drug, finerenone, approved for slowing kidney disease in diabetes
Finerenone (Kerendia) is the first agent approved from a novel class, the nonsteroidal mineralocorticoid receptor antagonists. But its role in...
News
What’s best for diabetes after metformin? GRADE outdated at outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, but the study is already outdated, said one...
News
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
News
Diabetes plus frequent sleep disturbances tied to higher mortality
People with diabetes who also have frequent sleep disturbances had a significantly higher mortality rate among UK Biobank participants.
News
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
News
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss.
News
Mavacamten boosts quality of life in patients with hypertrophic cardiomyopathy
Oral mavacamten significantly improved quality of life in a prespecified secondary endpoint from the EXPLORER-HCM pivotal trial.
News
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.
